EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line


Anticancer Research 24(1): 219-226
Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line
Background: Oxaliplatin (L-OHP), active in a wide range of human and animal tumours, also CDDP-resistant, possesses unique molecular characteristics of action. However, the mechanisms by which the damage induced by L-OHP triggers a death signal are not yet fully defined. Materials and Methods: After L-OHP treatment of the HCT15 human colon cancer cell line, apoptosis was evaluated by DNA laddering detection and by flow cytometry; the effect on specific caspase-3, -8 and -9 inhibitors, mitochondrial membrane permeability transition, cytochrome C release and expression of CD95 and CD95L were also assessed. Results: HCT15 cells underwent apoptosis when treated with all used drug concentrations (7-25 muM). Treatment of cells with L-OHP resulted in the activation of caspase-8, -9 and -3, in a mitochondrial membrane depolarisation, and in an increase of CD95 receptor and CD95 ligand levels. Conclusion: The results correlated well with the ability of L-OHP to induce apoptosis and give further insights into the mechanisms underlying the L-OHP-induced apoptosis of tumor cells.


Accession: 011772903

PMID: 15015600



Related references

Biologically synthesized green silver nanoparticles from leaf extract of Vitex negundo L induce growth-inhibitory effect on human colon cancer cell line HCT15. Process Biochemistry 48(2): 317-324, 2013

Influence of oxaliplatin combined with LCP on proliferation and apoptosis of colon cancer cell line HT29. Zhonghua Wei Chang Wai Ke Za Zhi 16(1): 84-88, 2014

Rapamycin synergizes with low-dose oxaliplatin in the HCT116 colon cancer cell line by inducing enhanced apoptosis. Oncology Letters 2(4): 643-647, 2012

Contribution of apoptosis in the synergistic combination of irinotecan and oxaliplatin in a human colon carcinoma cell line. Proceedings of the American Association for Cancer Research Annual Meeting 42: 103, March, 2001

Effect of hMSH6 cDNA expression on the phenotype of mismatch repair-deficient colon cancer cell line HCT15. Carcinogenesis 20(3): 373-382, 1999

Contribution of apoptosis in the cytotoxicity of the oxaliplatin-irinotecan combination in the HT29 human colon adenocarcinoma cell line. Biochemical Pharmacology 64(8): 1215-1226, 15 October, 2002

Contribution of apoptosis in the cytotoxicity of the oxaliplatin-irinotecan combination in the HT29 human colon adenocarcinoma cell line. Biochemical Pharmacology 64(8): 1215-1226, 2002

Clotrimazole induced apoptosis in human colon cancer cell line CCL229. Ai Zheng 21(6): 630-635, 2002

Resistance to azido thymidine cytotoxicity in the human colon tumor cell line hct15 is associated with enhanced removal of azt from cellular dna. Proceedings of the American Association for Cancer Research Annual Meeting 32: 358, 1991

Apoptosis induced by hyperthermia and verapamil in vitro in a human colon cancer cell line. International Journal Of Hyperthermia. 13(5): 547-557, 1997